创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
Progress in the development of new antiviral target drugs and strategies to overcome drug resistance
DAI Wenhao, LIU Hong
2024, 48(9): 641-643. DOI: 10.20053/j.issn1001-5094.2024.09.001
Abstract PDF
Drug Resistance Mechanisms of SARS-CoV-2 Main Protease and Chemical Strategies for Anti-Resistant Drugs
GU Manyu, YE Bing, GAO Shenghua, ZHAN Peng, LIU Xinyong
2024, 48(9): 644-660. DOI: 10.20053/j.issn1001-5094.2024.09.002
Abstract PDF
Research Progress of Small Molecular Antiviral Drugs Targeting G-quadruplex
HE Xingrui, LIU Mengting, WANG Zian, JIA Yicheng, YE Xiangyang, XIE Tian
2024, 48(9): 661-674. DOI: 10.20053/j.issn1001-5094.2024.09.003
Abstract PDF
Assembly Modulator of Hepatitis B Virus Capsid Protein and Its Inspiration for Drug Design
YANG Zechun, LIANG Minghui, WANG Mei, JIA Haiyong
2024, 48(9): 675-689. DOI: 10.20053/j.issn1001-5094.2024.09.004
Abstract PDF
Advances in Antiviral Agents Targeting Metalloproteins (2021-2023)
LI Baohu, XU Hui, TANG Kai, YANG Jinfei, ZHAN Peng
2024, 48(9): 690-706. DOI: 10.20053/j.issn1001-5094.2024.09.005
Abstract PDF
Research Progress of Soluble Guanylate Cyclase Stimulators and Activators
SHI Changyi, ZHAI Hongyang, LIU Shaojie, TANG Weifang
2024, 48(9): 707-715. DOI: 10.20053/j.issn1001-5094.2024.09.006
Abstract PDF
Enlightenment of FDA Warning Letter to Chinese Drug Manufacturers
Sun Xu, Hui Feng
2024, 48(9): 716-附页4. DOI: 10.20053/j.issn1001-5094.2024.09.007
Abstract PDF